Efficacy and tolerability of 1000-4000 mg per day of levetiracetam as add-on therapy in patients with refractory epilepsy

Author： Grant R. Shorvon S.D.

Publisher： Elsevier

ISSN： 0920-1211

Source： Epilepsy Research, Vol.42, Iss.2, 2000-12, pp. : 89-95

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapy

By Ben-Menachem E. Edrich P. Van Vleymen B. Sander J.W.A.S. Schmidt B.

Epilepsy Research, Vol. 53, Iss. 1, 2003-02 ,pp. : 57-64

Elsevier

Access to resources Recommend Favorite

Clinical efficacy of gabapentin as add-on therapy for resistant partial epilepsy

By Tomovic M. Ilic T. Dincic E. Jovicic A.

Electroencephalography and Clinical Neurophysiology, Vol. 103, Iss. 1, 1997-07 ,pp. : 135-136

Elsevier

Access to resources Recommend Favorite

Analysis of CSF amino acids in young patients with generalised refractory epilepsy during an add-on study with lamotrigine

By Eriksson A.-S. O'Connor W.T.

Epilepsy Research, Vol. 34, Iss. 1, 1999-03 ,pp. : 75-83

Elsevier

Access to resources Recommend Favorite

Dose-response effect of levetiracetam 1000 and 2000 mg/day in partial epilepsy

By Boon P. Chauvel P. Pohlmann-Eden B. Otoul C. Wroe S.

Epilepsy Research, Vol. 48, Iss. 1, 2002-01 ,pp. : 77-89

Elsevier

Access to resources Recommend Favorite

The efficacy of felbamate as add-on therapy to valproic acid in the Lennox-Gastaut syndrome

By Siegel H. Kelley K. Stertz B. Reeves-Tyer P. Flamini R. Malow B. Gaillard W.D. Ko D. Theodore W.H.

Epilepsy Research, Vol. 34, Iss. 2, 1999-04 ,pp. : 91-97

Elsevier

Access to resources Recommend Favorite